Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC01774 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;129-Ep400<tm1Fuku>/FukuRbrc |
Former Common name | mDom-KO, mDomino knockout mouse |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Dr. Rikiro Fukunaga at Osaka University in 2003. Part of exon 2 and inron 2 was replaced with a neomycin selection cassette. The mutant mice were backcrossed to C57BL/6. |
Strain description | B6.129-Ep400<tm1Fuku>. p400/mDomino (mammalian Domino) gene is an Swr1-class DNA-dependent ATPase that is a core subunit of a large chromatin-remodeling complex, and is currently suggested to play a unique function in histone variant exchange. The mDomino deficient mice are embryonic lethal and show anemic in appearance and slight deformity of the neural tubes. |
Colony maintenance | Backcross to C57BL/6 Backcross to C57BL/6 (Heterozygote x C57BL/6N) |
References | Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. Ueda T, Watanabe-Fukunaga R, Ogawa H, Fukuyama H, Higashi Y, Nagata S, Fukunaga R Genes Cells, 12, 581-592 (2007). 17535249 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Ep400 MGI:1276124 | E1A binding protein p400 | 5 | Ep400<tm1Fuku> | targeted mutation 1, Rikiro Fukunaga | |||
neo | neomycin resistance gene (E. coli) | 5 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 2 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase-1 promoter, E. coli neo, mouse mDomino genomic DNA |
Research application | Developmental Biology Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Genes Cells, 12, 581-592 (2007). RECIPIENT may only use the BIOLOGICAL RESOURCE for non-commercial academic research purpose. The RECIPIENT should negotiate with the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. For period of two (2) years after deposition by the DEPOSITOR to the REKEN BRC, the RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author. |
Depositor | Rikiro Fukunaga (Kyoto University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Jan 2008 |
BRC mice in Publications |
---|
Chevillard-Briet M, Quaranta M, Grézy A, Mattera L, Courilleau C, Philippe M, Mercier P, Corpet D, Lough J, Ueda T, Fukunaga R, Trouche D, Escaffit F. Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling. Hum Mol Genet 23(8) 2120-31(2014) 24287617 |